We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generics Take Hit As Court Rules Against Ranbaxy on Lipitor
Generics Take Hit As Court Rules Against Ranbaxy on Lipitor
December 30, 2005
A U.S. federal court ruled against Ranbaxy Laboratories after the company challenged two Pfizer patents for Lipitor, blocking generic drugmakers from capitalizing on Lipitor's success until 2011.